Role of S-Palmitoylation on IFITM5 for the Interaction with FKBP11 in Osteoblast Cells

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Tsukamoto, Takashi ^a,c   Li, Xianglan ^b   Morita, Hiromi ^b   Minowa, Takashi ^b   Aizawa, Tomoyasu ^a   Hanagata, Nobutaka ^a,b   Demura, Makoto ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE FOR MATERIALS SCIENCE   (Japan)

^c NAGOYA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

17 OCTADECYNOIC ACID; 2 BROMOPALMITIC ACID; CYSTEINE; FK 506 BINDING PROTEIN; FK 506 BINDING PROTEIN 11; INTERFERON INDUCED TRANSMEMBRANE 5 PROTEIN; MEMBRANE PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; COVALENT BOND; CYTOPLASM; GENE EXPRESSION; IMMUNOPRECIPITATION; NONHUMAN; OSSIFICATION; OSTEOBLAST; PALMITOYLATION; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; WESTERN BLOTTING;

ANIMALS; ENZYME INHIBITORS; LIPOYLATION; MEMBRANE PROTEINS; MICE; MULTIPROTEIN COMPLEXES; OSTEOBLASTS; OSTEOGENESIS; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; TACROLIMUS BINDING PROTEINS;

EID: 84884223024     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0075831     Document Type: Article

References (36)

1. Sällman Almén M, Bringeland N, Fredriksson R, Schiöth HB, (2012) The dispanins: a novel gene family of ancient origin that contains 14 human members. PLOS ONE 7: e31961. doi:10.1371/journal.pone.0031961. PubMed: 22363774.
2. Hickford DE, Frankenberg SR, Shaw G, Renfree MB, (2012) Evolution of vertebrate interferon inducible transmembrane proteins. BMC Genomics 13: 155. doi:10.1186/1471-2164-13-155. PubMed: 22537233.
3. Saitou M, Barton SC, Surani MA, (2002) A molecular programme for the specification of germ cell fate in mice. Nature 418: 293-300. doi:10.1038/nature00927. PubMed: 12124616.
4. Lange UC, Saitou M, Western PS, Barton SC, Surani MA, (2003) The fragilis interferon-inducible gene family of transmembrane proteins is associated with germ cell specification in mice. BMC Dev Biol 3: 1. doi:10.1186/1471-213X-3-1. PubMed: 12659663.
5. Tanaka SS, Nagamatsu G, Tokitake Y, Kasa M, Tam PPL, et al. (2004) Regulation of expression of mouse interferon-induced transmembrane protein like gene-3, Ifitm3 (mil-1, fragilis), in germ cells. Dev Dyn 230: 651-659. doi:10.1002/dvdy.20085. PubMed: 15254899.
6. Evans SS, Lee DB, Han T, Tomasi TB, Evans RL, (1990) Monoclonal antibody to the interferon-inducible protein Leu-13 triggers aggregation and inhibits proliferation of leukemic B cells. Blood 76: 2583-2593. PubMed: 2265250.
7. Evans SS, Collea RP, Leasure JA, Lee DB, (1993) IFN-alpha induces homotypic adhesion and Leu-13 expression in human B lymphoid cells. J Immunol 150: 736-747. PubMed: 8423337.
8. Deblandre GA, Marinx OP, Evans SS, Majjaj S, Leo O, et al. (1995) Expression cloning of an interferon-inducible 17-kDa membrane protein implicated in the control of cell growth. J Biol Chem 270: 23860-23866. doi:10.1074/jbc.270.40.23860. PubMed: 7559564.
9. Brass AL, Huang I-C, Benita Y, John SP, Krishnan MN, et al. (2009) The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell 139: 1243-1254. doi:10.1016/j.cell.2009.12.017. PubMed: 20064371.
10. Yount JS, Moltedo B, Yang Y-Y, Charron G, Moran TM, et al. (2010) Palmitoylome profiling reveals S-palmitoylation-dependent antiviral activity of IFITM3. Nat Chem Biol 6: 610-614. doi:10.1038/nchembio.405. PubMed: 20601941.
11. Feeley EM, Sims JS, John SP, Chin CR, Pertel T, et al. (2011) IFITM3 Inhibits Influenza A Virus Infection by Preventing Cytosolic Entry. PLOS Pathog 7: e1002337. PubMed: 22046135.
12. Everitt AR, Clare S, Pertel T, John SP, Wash RS, et al. (2012) IFITM3 restricts the morbidity and mortality associated with influenza. Nature 484: 519-523. doi:10.1038/nature10921. PubMed: 22446628.
13. Bailey CC, Huang I-C, Kam C, Farzan M, (2012) Ifitm3 limits the severity of acute influenza in mice. PLOS Pathog 8: e1002909. PubMed: 22969429.
14. Yount JS, Karssemeijer RA, Hang HC, (2012) S-palmitoylation and ubiquitination differentially regulate interferon-induced transmembrane protein 3 (IFITM3)-mediated resistance to influenza virus. J Biol Chem 287: 19631-19641. doi:10.1074/jbc.M112.362095. PubMed: 22511783.
15. Jiang D, Weidner JM, Qing M, Pan X-B, Guo H, et al. (2010) Identification of five interferon-induced cellular proteins that inhibit west nile virus and dengue virus infections. J Virol 84: 8332-8341. doi:10.1128/JVI.02199-09. PubMed: 20534863.
16. Lu J, Pan Q, Rong L, He W, Liu S-L, et al. (2011) The IFITM proteins inhibit HIV-1 infection. J Virol 85: 2126-2137. doi:10.1128/JVI.01531-10. PubMed: 21177806.
17. Huang I-C, Bailey CC, Weyer JL, Radoshitzky SR, Becker MM, et al. (2011) Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus. PLOS Pathog 7: e1001258. PubMed: 21253575.
18. Moffatt P, Gaumond M-H, Salois P, Sellin K, Bessette M-C, et al. (2008) Bril: a novel bone-specific modulator of mineralization. J Bone Miner Res 23: 1497-1508. doi:10.1359/jbmr.080412. PubMed: 18442316.
19. Hanagata N, Li X, Morita H, Takemura T, Li J, et al. (2011) Characterization of the osteoblast-specific transmembrane protein IFITM5 and analysis of IFITM5-deficient mice. J Bone Miner Metab 29: 279-290. doi:10.1007/s00774-010-0221-0. PubMed: 20838829.
20. Liu Y, Liu H, Titus L, Boden SD, (2012) Natural antisense transcripts enhance bone formation by increasing sense IFITM5 transcription. Bone 51: 933-938. doi:10.1016/j.bone.2012.07.024. PubMed: 22884724.
21. Kasaai B, Gaumond M-H, Moffatt P, (2013) Regulation of the Bone-restricted ifitm-like (Bril) gene transcription by Sp and Gli family members and CpG methylation. J Biol Chem 288: 13278-13294. doi:10.1074/jbc.M113.457010. PubMed: 23530031.
22. Diamond MS, Farzan M, (2013) The broad-spectrum antiviral functions of IFIT and IFITM proteins. Nat Rev Immunol 13: 46-57. PubMed: 23237964.
23. Aicart-Ramos C, Valero RA, Rodriguez-Crespo I, (2011) Protein palmitoylation and subcellular trafficking. Biochim Biophys Acta 1808: 2981-2994. doi:10.1016/j.bbamem.2011.07.009. PubMed: 21819967.
24. Chutiwitoonchai N, Hiyoshi M, Hiyoshi-Yoshidomi Y, Hashimoto M, Tokunaga K, et al. (2013) Characteristics of IFITM, the newly identified IFN-inducible anti-HIV-1 family proteins. Microbes Infect 15: 280-290. doi:10.1016/j.micinf.2012.12.003. PubMed: 23376165.
25. Hach JC, McMichael T, Chesarino NM, Yount JS, (2013) Palmitoylation on conserved and non-conserved cysteines of murine IFITM1 regulates its stability and anti-influenza A virus activity. J Virol. doi:10.1128/JVI.00621-13.
26. Siegrist F, Ebeling M, Certa U, (2011) The small interferon-induced transmembrane genes and proteins. J Interferon Cytokine Res 31: 183-197. doi:10.1089/jir.2010.0112. PubMed: 21166591.
27. Hanagata N, Takemura T, Monkawa A, Ikoma T, Tanaka J, (2007) Phenotype and gene expression pattern of osteoblast-like cells cultured on polystyrene and hydroxyapatite with pre-adsorbed type-I collagen. J Biomed Mater Res A 83: 362-371. PubMed: 17450577.
28. Hanagata N, Li X, (2011) Osteoblast-enriched membrane protein IFITM5 regulates the association of CD9 with an FKBP11-CD81-FPRP complex and stimulates expression of interferon-induced genes. Biochem Biophys Res Commun 409: 378-384. doi:10.1016/j.bbrc.2011.04.136. PubMed: 21600883.
29. Martin BR, Cravatt BF, (2009) Large-scale profiling of protein palmitoylation in mammalian cells. Nat Methods 6: 135-138. doi:10.1038/nmeth.1293. PubMed: 19137006.
30. Yount JS, Charron G, Hang HC, (2012) Bioorthogonal proteomics of 15-hexadecynyloxyacetic acid chemical reporter reveals preferential targeting of fatty acid modified proteins and biosynthetic enzymes. Bioorg Med Chem 20: 650-654. doi:10.1016/j.bmc.2011.03.062. PubMed: 21524915.
31. Webb Y, Hermida-Matsumoto L, Resh MD, (2000) Inhibition of protein palmitoylation, raft localization, and T cell signaling by 2-bromopalmitate and polyunsaturated fatty acids. J Biol Chem 275: 261-270. doi:10.1074/jbc.275.1.261. PubMed: 10617614.
32. Charron G, Zhang MM, Yount JS, Wilson J, Raghavan AS, et al. (2009) Robust fluorescent detection of protein fatty-acylation with chemical reporters. J Am Chem Soc 131: 4967-4975. doi:10.1021/ja810122f. PubMed: 19281244.
33. Zheng B, Deran M, Li X, Liao X, Fukata M, et al. (2013) 2-Bromopalmitate Analogues as Activity-Based Probes To Explore Palmitoyl Acyltransferases. J Am Chem Soc 135: 7082-7085. doi:10.1021/ja311416v. PubMed: 23631516.
34. Davda D, Azzouny El Ma, Tom CTMB, Hernandez JL, Majmudar JD, et al. (2013) Profiling Targets of the Irreversible Palmitoylation Inhibitor 2-Bromopalmitate. ACS Chem Biol: ([MedlinePgn:]) doi:10.1021/cb400380s. PubMed: 23844586.
35. Marino M, Ascenzi P, Acconcia F, (2006) S-palmitoylation modulates estrogen receptor alpha localization and functions. Steroids 71: 298-303. doi:10.1016/j.steroids.2005.09.011. PubMed: 16274718.
36. Linder ME, Deschenes RJ, (2007) Palmitoylation: policing protein stability and traffic. Nat Rev Mol Cell Biol 8: 74-84. doi:10.1038/nrm2084. PubMed: 17183362.